as 05-30-2025 4:00pm EST
Stocks
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
Founded: | 2016 | Country: | United States |
Employees: | N/A | City: | MENLO PARK |
Market Cap: | 877.1M | IPO Year: | N/A |
Target Price: | $31.50 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -58.52 | EPS Growth: | N/A |
52 Week Low/High: | $12.33 - $63.99 | Next Earning Date: | 05-13-2025 |
Revenue: | $130,711,000 | Revenue Growth: | 30.47% |
Revenue Growth (this year): | 19.98% | Revenue Growth (next year): | 17.52% |
GRAL Breaking Stock News: Dive into GRAL Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
16 minutes ago
Yahoo Finance
17 minutes ago
GlobeNewswire
17 minutes ago
GlobeNewswire
17 minutes ago
PR Newswire
17 minutes ago
CNW Group
17 minutes ago
AFP
19 minutes ago
Moneywise
25 minutes ago
The information presented on this page, "GRAL GRAIL INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.